L'analisi ad interim conferma l'attività nel carcinoma del pancreas localmente avanzato del protocollo chemioterapico "FOLFIRINOX modificato", che permette di eseguire resezioni pancreatiche estese in una percentuale rilevante di pazienti affetti da adenocarcinoma del pancreas in stadio III con risultati comparabili a quelli ottenuti nei pazienti affetti da malattia "primary resectable". Ulteriori dati da coorti di pazienti di maggiori dimensioni sono auspicabili prima di giungere a conclusioni definitive.
RINGRAZIAMENTI
Un caro ringraziamento è diretto a tutti i pazienti ed alle loro famiglie, per la speranza, il coraggio e la dignità mostrateci nella malattia. Ringrazio altresì tutto il personale infermieristico, sia del Reparto Degenze sia dell'Ambulatorio Chirurgico (Luca, Claudia e Fabrizio) per l'amore, la pazienza e la dedizione rivolta sia ai pazienti sia ai medici. Ringrazio tutti i Colleghi Medici che condividono quotidianamente le speranze dei pazienti affetti da malattie del pancreas.
GMpmm Pagina 38
Bibliografia
Adler, G. et al., 2007. S3-Guidelines ‘‘Exocrine pancreatic cancer’’. Z Gastroenterol, Volume 45, p. 487–523. AJCC, A. J. C. o. C., 2010. AJCC Cancer Staging Manual. Seventh Edition a cura di Chicago, Illinois: Springer Science and Business Media.
Bagyanszki, M. & Bodi, N., 2012. Diabetes-related alterations in the enteric nervous system and its microenviroment. World Journal of Diabetes, 3(5), pp. 80-93.
Bakkevold, K., Arnesjo, B., Dahl, O. & Kambestad, B., 1993. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater–results of a controlled, prospective, randomised multicentre study.. Eur J Cancer, Volume 29A, p. 698–703.
Bassi, C. et al., 2005. Postoperative pancreatic fistula: An international study group (ISGPF) definition..
Surgery, 138(1), pp. 8-13.
Bilimoria, K. et al., 2007. National failure to operate on early stage pancreatic cancer.. Ann Surg, Volume 246, pp. 173-180.
Boone, B. & al, e., 2012. Outcomes with FOLFIRINOX for locally advanced pancreatic cancer.. Journal of
Clinical Oncology, Volume 30, p. suppl 34; abstr 256.
Bozic, I. et al., 2013. Evolutionary dynamics in response to targeted combination therapy. eLife, Volume 2. Castellanos, J. A., Merchant, N. B. & Nagathihalli, N. S., 2013. Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells. OncoTargets and Therapy, Volume 6, pp. 1261- 1267.
Dindo, D., Demartines, N. & Clavien, P., 2004. Classification of surgical complications. Annals of Surgery, 240(2), pp. 205-213.
Esposito, I. et al., 2008. Most pancreatic cancer resections are R1 resections.. Ann Surg Oncol, Volume 15, p. 1651–1660.
Gaedcke, J. et al., 2010. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Archives of Surgery, April, 395(4), pp. 451-458.
Gillen, S. et al., 2010. Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages. PLoS Medicine, April, 7(4), pp. 1-15.
GITSG, 1987. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.. Cancer, Volume 59, p. 2006– 2010.
Heinemann, V. et al., 2008. Metaanalysis of randomized trials: evaluation of benefit from gemcitabine- based combination chemotherapy applied in advanced pancreatic cancer.. BMC Cancer, Volume 8, p. 82. Hosein, P. et al., 2012. A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline- resectable locally advanced pancreatic adenocarcinoma.. BMC Cancer, Volume 12, p. 199.
GMpmm Pagina 39 Kleeff, J., Friess, H. & Buchler, M., 2007. Neoadjuvant therapy for pancreatic cancer.. Br J Surg, Volume 94, pp. 261-262.
Kleeff, J. et al., 2007. Surgery for recurrent pancreatic ductal adenocarcinoma.. Ann Surg, Volume 245, p. 566–572.
Klinkenbijl, J. et al., 1999. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.. Ann Surg, Volume 230, p. 776–782.
Masi, G. et al., 2007. Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed Radical Surgery of Metastases. Journal of Clinical Oncology, May.Volume 25.
Mazzeo, S. et al., 2007. Evaluation of vascular infiltration in resected patients for pancreatic cancer:
comparison among multidetector CT, intraoperative findings and histopathology. Abdominal Imaging, Nov, 32(6), pp. 737-742.
Mukherjee, S. & al, e., 2012. SCALOP: Results of a randomized phase II study of induction chemotherapy followed by gemcitabine (G) or capecitabine (Cap) based chemoradiation (CRT) in locally advanced pancreatic cancer (LANPC).. Journal of Clinical Oncology, Volume 30, p. suppl 34; abstr LBA 146.
Neoptolemos, J. et al., 2004. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.. N Engl J Med, Volume 350, p. 1200–1210.
Oettle, H. et al., 2007. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative intent resection of pancreatic cancer: a randomized controlled trial.. JAMA, Volume 297, p. 267– 277.
Pedersen, S. F., Hoffmann, E. K. & Novak, I., 2013. Cell volume regulation in epithelial physiology and cancer. Frontiers in Physiology, Volume 4, pp. 1-12.
Penchev, V. R., Rasheed, Z. A., Maitra, A. & Matsui, W., 2012. heterogeneity and targeting of pancreatic cancer stem cells. Clinical Cancer Research, 18(16), pp. 4277-4284.
Peng, W., Tang, H. & Li, D., 2012. Insights into Pancreatic Cancer Etiology from Pathway Analysis of Genome-Wide Association Study Data. PLoS ONE, 7(10), p. e46887.
Pessaux, P., Regent, N. & Amaud, J., 2003. resection of the retroportal pancreatic lamina during pancreaticoduodenectomy: first dissection of the superiore mesenteric artery. Annales de Chirurgie, November, 128(9), pp. 633-636.
Pilepich, M. & Miller, H., 1980. Preoperative irradiation in carcinoma of the pancreas.. Cancer, Volume 46, p. 1945–1949.
Riediger, H. et al., 2009. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.. Journal Gastrointestinal Surgery, 13(7), pp. 1337-1344.
Shrikhande, S. et al., 2007. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.. Ann Surg Oncol, Volume 14, pp. 118-127.
GMpmm Pagina 40 Stocken, D. et al., 2005. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.. Br J
Cancer, Volume 92, p. 1372–1381.
Sultana, A. et al., 2008. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.. Br J Cancer, Volume 99, pp. 6-13.
Sumrall, B., 2012. A single-center experience of modified FOLFOX-6 in locally advanced and metastatic pancreatic adenocarcinomas. Journal of Clinical Oncology, Volume 30, p. suppl 34; abstr 303.
Takada, T. et al., 2002. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary
carcinoma.. Cancer, Volume 95, p. 1685–1695.
Tanaka, M. et al., 2012. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology, Volume 12, pp. 183-197.
Tempero, M. et al., 2008. National Comprehensive Cancer Network: Practice guidelines in oncology— v.1.2008: Pancreatic adenocarcinoma.. Available at www.nccn.org..
Tempero, M. et al., 2007. Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.. J Natl
Compr Canc Netw, Volume 5, p. 998–1033.
Tempero, M., Behrman, S., Benson, A. & al., e., 2013. NCCN Guidelines Version 1.2013 Pancreatic Adenocarcinoma. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.
Thierry, C. et al., 2011. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer. T he New England
Journal of Medicine, Maggio, Volume 364, pp. 1817-1825.
Valdovinos, M., Camilleri, M. & Zimmerman, B., 1993. Chronic diarrhea in diabetes mellitus: mechanisms and approach to diagnosis and treatment. Mayo Clinic Proceedings, July, 68(7), pp. 691-702.
Van Laethem, J. et al., 2009. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiation after curative resection for pancreatic cancer: updated results of a randomized EORTC/FFCD/GERCOR phase II study (40013-22012/9203).. J Clin Oncol, Volume 27, p. 4527.
Verbeke, C. & Gladhaug, I., 2012. Resection margin involvement and tumor origin in pancreatic head cancer. British Journal of Surgery, August, 99(8), pp. 1036-1049.
Verbeke, C. et al., 2006. Redefining the R1 resection in pancreatic cancer.. Br J Surg, Volume 93, p. 1232– 1237.
Verbeke, C. & Menon, K., 2009. Redefining resection margin status in pancreatic cancer. HPB, June, 11(4), pp. 282-289.
Whittington, R. et al., 1984. Multimodality therapy of localized unresectable pancreatic adenocarcinoma..
GMpmm Pagina 41 ICONOGRAFIA (Figura 3-Figura 17)
GMpmm Pagina 42
GMpmm Pagina 43
FIGURA 5: ISOLAMENTO VENA PORTA
FIGURA 6: ISOLAMENTO VASI MESENTERICI SUPERIORI AL DI SOTTO DEL BORDO INFERIORE DEL PANCREAS
GMpmm Pagina 44
FIGURA 7: ISOLAMENTO RAMI DIGIUNALI ALL'INTERNO DEL MESENTERE
GMpmm Pagina 45
FIGURA 9: SCHELETRIZZAZIONE DELLA SMA LUNGO IL LATO DESTRO
GMpmm Pagina 46
FIGURA 11: RICOSTRUZIONE DELLA VENA PORTA
GMpmm Pagina 47
GMpmm Pagina 48
GMpmm Pagina 49
GMpmm Pagina 50
GMpmm Pagina 51
FIGURA 15a: ENCASEMENT ARTERIA MESENTERICA SUPERIORE, PRE- NEOADIUVANTE
GMpmm Pagina 52
FIGURA 15b: ENCASEMENT ARTERIA MESENTERICA SUPERIORE, PRE- NEOADIUVANTE (RICOSTRUZIONE TC CASO PRECEDENTE)
GMpmm Pagina 53
FIGURA 15c: ENCASEMENT ARTERIA MESENTERICA SUPERIORE, NEOADIUVANTE TERMINATA
GMpmm Pagina 54
FIGURA 15d: ENCASEMENT ARTERIA MESENTERICA SUPERIORE, NEOADIUVANTE TERMINATA
GMpmm Pagina 55
FIGURA 16a: ENCASEMENT ARTERIA MESENTERICA SUPERIORE FINO ALLE DIRAMAZIONI DIGIUNALI
GMpmm Pagina 56
FIGURA 16b: ENCASEMENT ARTERIA MESENTERICA SUPERIORE FINO ALLE DIRAMAZIONI DIGIUNALI (RICOSTRUZIONE TC DEL CASO PRECEDENTE)
GMpmm Pagina 57